Fibroblast growth factor 23 (FGF-23) is an early predictor of mortality in patients with cardiac arrest

Article ID	Journal	Published Year	Pages	File Type
5997402	Resuscitation	2016	6 Pages	PDF

Abstract

This study demonstrates elevated FGF-23 serum levels to be potentially helpful in prediction of mortality and poor neurological outcome as early as 24Â h post cardiac arrest.

Keywords

NSE GFR RAAS NT-proBNP PEA hsTnT BLS ROC FGF-23 HRR PCT ACLS ROSC TTM High-sensitive troponin T CPC AUC neuron specific enolase Cardiopulmonary resuscitation CPR Cardiac arrest Return of spontaneous circulation Biomarker Ventricular tachycardia Cerebral performance category confidence interval fibroblast growth factor 23 pulseless electrical activity Ventricular fibrillation Targeted temperature management Mortality receiver operating curve area under the curve neurological outcome Glomerular filtration rate C-reactive protein CRP Procalcitonin Basic Life Support Advanced cardiac life support brain natriuretic peptide

Related Topics

Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine

Preview

Fibroblast growth factor 23 (FGF-23) is an early predictor of mortality in patients with cardiac arrest

Authors

Sebastian Spaich, Thomas Zelniker, Philipp Endres, Jan Stiepak, Lorenz Uhlmann, Raffi Bekeredjian, Emmanuel Chorianopoulos, Evangelos Giannitsis, Johannes Backs, Hugo A. Katus, Michael R. Preusch,